Health Care

'Pharma Bro' firm reaches $40M settlement in gouging case

A company once owned by "Pharma Bro" Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug, the Federal Trade Commission announced Tuesday.

Omicron halts travel industry's recovery plans

Tourism businesses that were just finding their footing after nearly two years of devastation wrought by the COVID-19 pandemic are being rattled again as countries throw up new barriers to travel in an effort to contain the omicron variant.

Japan postpones new flight reservations due to omicron

Japan continued its aggressive stance against a new coronavirus variant on Wednesday, asking international airlines to stop taking new reservations for all flights arriving in the country until the end of December in a further tightening of already strict border controls.

Pfizer to offer COVID-19 vaccine for European kids 5-11

The European Union's drug regulator on Thursday authorized Pfizer’s coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.

Biogen shares slip as Alzheimer's drug faces new setback

Shares of Biogen slipped nearly 4% in pre-market trading Wednesday after the biotech company's new Alzheimer's drug Aduhelm (aducanumab) received a "negative trend vote" from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP).

Pfizer CEO says COVID pill a 'game changer'

Pfizer CEO Albert Bourla called Friday’s announcement that the company’s experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults “a game-changer.”